Infectious Diseases Study Experience
The need for effective therapies to treat infectious diseases is increasing rapidly, and developing those therapies is more complex than ever before. At PPD, we understand the challenges and help our clients navigate and minimize the complexities. This begins with well-written concepts and protocols that serve as the roadmap to developing the optimal plan for anti-infective, antiviral and vaccine studies.
With our global network of therapeutic and regulatory experts, we help clients understand standards of care and regulations every step of the way to ensure timelines are met.
In the past five years, our infectious diseases team has effectively:
- Conducted or supported more than 280 protocols1
- Enrolled in excess of 281,000 patients at more than 9,600 sites1
In the past five years, we have conducted infectious disease trials in: Argentina, Australia, Austria, Belgium, Botswana, Brazil, Bulgaria, Canada, Chile, Colombia, Costa Rica, Czech Republic, Denmark, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Ireland, Israel, Italy, Lebanon, Mexico, Netherlands, New Zealand, Norway, Panama, Peru, Philippines, Poland, Portugal, Puerto Rico, Romania, Russia, Singapore, Slovak Republic, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, Turkey, Ukraine, United Kingdom and United States.
1. These numbers don't include our work in the nontraditional services sector, which is managed separately.
